Q3 2016

Source filing unavailable

Q3 2016 · —

Revenue

$21.67M

+142.1% vs Q3 2015

Net Income

-$33.63M

N/M vs Q3 2015

EPS Diluted

-$0.39

N/M vs Q3 2015

Gross Profit$10,556,000+220.5%

Operating Income-$28,265,000N/M

Operating Cash Flow-$33,496,000

Same quarter

Metric	Q3 2016	Q3 2015	Q3 2014
Revenue	$21.67M	$8.95M	$4.37M
Net Income	-$33.63M	-$26.02M	-$18.32M
EPS Diluted	-$0.39	-$2.09	-$1.45

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NovoCure Ltd · CIK 1645113 · Engraved from SEC EDGAR